| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Lebar James serves as a Director at ZOMDF. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $2K at current prices.
The biggest single holding is ZOMDF (~$2K) as Director. The recent filings there lean toward selling, a net 200,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2018 | ZOMDF Zomedica Corp. | Director | Sell | 200,000 | $2.15 | $430,000.00 | -90.9% |